The Dawn of a New Era: Transforming Our Domestic Response to Hepatitis B & C
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding Support for the 2-day meeting was provided by independent educational grants from Gilead Sciences, Inc, Bristol-Myers Squibb, and Vertex Pharmaceuticals. This activity is supported by independent educational grants provided by Gilead Sciences Inc. and Vertex Pharmaceuticals.
PII: S0016-5085(10)00262-3
doi:10.1053/j.gastro.2010.02.034
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

